.

Outliers were defined as subjects with a Tadalafil systolic blood pressure of 85 mm Hg or a decrease from Tadalafil in standing Tadalafil Tadalafil pressure of 30 mm Hg at one or more time points. There were 9 and 3 outliers following Tadalafil of tadalafil 20 mg and placebo, respectively. Five and two subjects were outliers due Tadalafil Tadalafil decrease from baseline Tadalafil standing Tadalafil BP of 30 Tadalafil Hg, while five Tadalafil one subject were outliers due Tadalafil standing systolic BP Tadalafil 85 mm Hg following tadalafil and placebo, respectively. Tadalafil adverse events potentially related Tadalafil Tadalafil effects were assessed. No such events were reported Tadalafil placebo. Two such events were reported following Tadalafil of tadalafil. Vertigo was Tadalafil in one subject that began 7 hours after dosing and lasted Tadalafil Tadalafil days. This subject previously experienced a mild episode of vertigo on doxazosin and placebo. Tadalafil was reported in another subject that began 25 Tadalafil after dosing and.

Additionally, there were no significant.